Lupin inks deal with Ascend for marketing Suprax in US

New Delhi, Jun 23 (UNI) Lupin Ltd today said it has signed an agreement with Ascend Therapeutics Inc for marketing Suprax 400 mg tablets in the US.

Under the terms of the alliance, Ascend Therapeutics will initiate promotion of Suprax, an antibiotic used in the treatment of Urinary Tract Infections (UTI) and other bacterial infections, in the US during this month, the company said in a statement.

Ascend has a 50-person women's health sales force which will detail the product primarily to obstetricians and Gynecolosgists and Lupin will continue to promote the product to pediatricians and family practitioners.

UNI SG SR BD1602